Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05

FDA recall notice · announced April 3, 2019 · Allergan Sales

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05

Reason for recall

cGMP Deviations

Notes

Distribution: TN only
Lot/code information: Lot#: 99946 Exp. January 16, 2021
Quantity: 72 bottles
Status: Terminated
Products in this recall event:
- Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05 (D-1056-2019)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.